SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000885590-12-000078
Filing Date
2012-12-11
Accepted
2012-12-11 17:07:39
Documents
2
Period of Report
2012-12-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 7559
2 POWER OF ATTORNEY poaweldon.txt EX-24 3407
  Complete submission text file 0000885590-12-000078.txt   12518
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4787 LEVY STREET MONTREAL A8 H4R 2P9
Business Address
Weldon Ryan (Reporting) CIK: 0001564233 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 121257027